mRNA vaccine more effective booster to ChAdOx1 nCoV-19

Mechanism underlying the emergence of virus variants unravelled
22 October 2021
Study shows first responders at higher risk of COVID-19 infection
22 October 2021

mRNA vaccine more effective booster to ChAdOx1 nCoV-19

(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe.

Comments are closed.